Evidence map›Paper›PMID 33558807›Full record

ReviewEnvironmental chemistry letters2021

Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review.

Erwan Sallard, José Halloy, Didier Casane, Etienne Decroly, Jacques van Helden

Open access · hybridAbstract readReview
In one paragraph

Review in Environmental chemistry letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. In Silico Analysis of CMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. A review of the effect of COVID-19 on immune responses of the body.Journal of family medicine and primary care · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Erwan SallardÉcole Normale Supérieure de Paris, 45 rue d'Ulm, 75005 Paris, France.ORCID 0000-0002-2324-3633
José HalloyUniversité de Paris, CNRS, LIED UMR 8236, 85 bd Saint-Germain, 75006 Paris, France.ORCID 0000-0003-1555-2484
Didier CasaneUniversité Paris-Saclay, CNRS, IRD, UMR Évolution, Génomes, Comportement et Écologie, 91198 Gif-sur-Yvette, France.ORCID 0000-0001-5463-1092
Etienne Decroly *Aix-Marseille Univ, CNRS, UMR 7257, AFMB, Case 925, 163 Avenue de Luminy, 13288 Marseille Cedex 09, France.ORCID 0000-0002-6046-024X
Jacques van Helden *CNRS, Institut Français de Bioinformatique, IFB-core, UMS 3601, Evry, France.ORCID 0000-0002-8799-8584
Centre National de la Recherche Scientifique · FRÉcole Normale Supérieure - PSL · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 is a new human coronavirus (CoV), which emerged in China in late 2019 and is responsible for the global COVID-19 pandemic that caused more than 97 million infections and 2 million deaths in 12 months. Understanding the origin of this virus is an important issue, and it is necessary to determine the mechanisms of viral dissemination in order to contain future epidemics. Based on phylogenetic inferences, sequence analysis and structure-function relationships of coronavirus proteins, informed by the knowledge currently available on the virus, we discuss the different scenarios on the origin-natural or synthetic-of the virus. The data currently available are not sufficient to firmly assert whether SARS-CoV2 results from a zoonotic emergence or from an accidental escape of a laboratory strain. This question needs to be solved because it has important consequences on the risk/benefit balance of our interactions with ecosystems, on intensive breeding of wild and domestic animals, on some laboratory practices and on scientific policy and biosafety regulations. Regardless of COVID-19 origin, studying the evolution of the molecular mechanisms involved in the emergence of pandemic viruses is essential to develop therapeutic and vaccine strategies and to prevent future zoonoses. This article is a translation and update of a French article published in Médecine/Sciences, August/September 2020 (10.1051/medsci/2020123). Supplementary Information: The online version of this article (10.1007/s10311-020-01151-1) contains supplementary material, which is available to authorized users.

Indexed as

BioinformaticsBiosafetyCoronavirusCovid-19FurinGain of functionGenome analysisPandemicPhylogenySARS-CoV-2Spike proteinVirologyZoonosis

Identifiers

PMID33558807
PMCPMC7859469
OpenAlexW3128357250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.